Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk

Follow Drugslib on

By Andria Park Huynh HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 26, 2026.

via HealthDay

TUESDAY, May 26, 2026 — The Trump administration has issued a directive shutting key U.S. health research officials out of global discussions on virus outbreaks, according to CNN.

Specifically, officials from the National Institute of Allergy and Infectious Diseases (NIAID) have been barred from communicating with the World Health Organization (WHO).

While the prohibition has been in place since the hantavirus outbreak aboard the MV Hondius cruise ship last month, communication limits were relaxed slightly in the past week as talks around an African Ebola outbreak increased.

Now, NIAID officials can attend virtual WHO meetings only in small groups and only in a “listening capacity,” according to a May 18 email from a senior NIAID official to staff obtained by CNN.

If needed, follow-ups to meetings would be handled by the U.S. Department of Health and Human Services, the agency that oversees NIAID.

“We’ll be operating in the same manner for Ebola as we have been doing for Hantavirus, assembling a small groups of experts — no more than three — to participate,” the email said. “Should we have legitimate research questions or countermeasure testing ideas, we can bring those up through the proper chain of command.”

The directive follows Trump administration moves to step back from global health forums, including withdrawal in January from WHO, which met widespread criticism from public health officials. The moves are an outgrowth of Republican frustration with WHO’s handling of the COVID-19 pandemic.

Jeremy Konyndyk, president of Refugees International and a former State Department official in the Obama and Biden administrations, noted that the chains of communication that would have alerted the U.S. to the unfolding Ebola crisis are now gone.

“We have public health leadership in this country now that have written off most of the institutions with global health,” Konyndyk told CNN.

The restrictions dovetail with what some are calling an unprecedented health leadership vacuum. The surgeon general’s job is vacant, the NIAID's acting director, Dr. Jeffery Taubenberger, recently quit. The U.S. Food & Drug Administration lost its commissioner this month, and multiple senior officials have left the U.S. Centers for Disease Control and Prevention (CDC), according to CNN.

“If there were multiple U.S. government health partners seeing clusters of unexplained viral hemorrhagic fever, they would have been sending that up the chain. Except that they didn’t really have anyone to send it up the chain to anymore,” Konyndyk said.

Last week, WHO's assessment level of the Ebola outbreak in the Democratic Republic of Congo was upgraded from “high” to “very high.”

No cases have yet been seen in the United States, though one American Dr. Peter Stafford, an aid worker who contracted the illness in Africa, is being treated in Germany. His family is also in quarantine, and another American is being monitored, according to CNN.

The CDC has said it is working “around the clock” with partners to address the Ebola outbreak. The international risk remains low, according to WHO.

Sources

  • CNN, May 26, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-05-27 03:04

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords